A vs BIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
A
BIO
Investment Advisor Scores
BIO
Oct 21, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | A | BIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 23.8663 | 41.3223 | A |
| PEG Ratio | 1.3652 | 1.1905 | BIO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 8.1% | -0.1% | A |
| Earnings Growth | 8.5% | 18.7% | BIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.9/100 | 70.1/100 | BIO |
| Profit Margin | 19.5% | 8.6% | A |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | STRONG BUY | BIO |
Relative Price Performance (Last 90 Days)
Current Technical Phase
A
MarkupPrice above SMA50, rising 50-day trend (8.9% over 20 days), RSI 66
BIO
NeutralMixed signals - no dominant trend phase, RSI 46
Fundamentals Snapshot
| Metric | A | BIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 26.3 | 37.0 |
| Trailing P/E | 34.1 | 44.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.5% | 0.5% |
| Operating Margin | 0.3% | 0.1% |
| EPS | 5.07 | 7.89 |
| Dividend Yield | 0.01% | — |